You are here:
03 April 2020 / deal

Loyens & Loeff advised Karo Pharma AB on Swiss aspects of the acquisition of all shares in Hygis SA

Hygis SA is a Swiss distributing company with exclusive distribution rights to Karo Pharma’s brands MultiGyn and MultiMam. This acquisition will further strengthen Karo Pharma’s direct presence in the DACH region.

How to structure a joint venture in real estate?

Karo Pharma is a pharmaceutical company founded in 1987 specialized in sales and marketing of prescription pharmaceuticals and over-the-counter products sold in pharmacies and retail. Karo Pharma is listed on Nasdaq Stockholm Mid Cap.

Loyens & Loeff advised Karo Pharma in the transaction with a team led by Marco Toni and consisted of Fabian Sutter, Valérie Schrämli and Renate Loretan-Bührle.